A Multitarget Approach against Neuroinflammation : Alkyl Substituted Coumarins as Inhibitors of Enzymes Involved in Neurodegeneration
Neurodegenerative disorders (NDs) include a large range of diseases characterized by neural dysfunction with a multifactorial etiology. The most common NDs are Alzheimer's disease and Parkinson's disease, in which cholinergic and dopaminergic systems are impaired, respectively. Despite different brain regions being affected, oxidative stress and inflammation were found to be common triggers in the pathogenesis and progression of both diseases. By taking advantage of a multi-target approach, in this work we explored alkyl substituted coumarins as neuroprotective agents, capable to reduce oxidative stress and inflammation by inhibiting enzymes involved in neurodegeneration, among which are Carbonic Anhydrases (CAs), Monoamine Oxidases (MAOs), and Cholinesterases (ChEs). The compounds were synthesized and profiled against the three targeted enzymes. The binding mode of the most promising compounds (7 and 9) within MAO-A and -B was analyzed through molecular modeling studies, providing and explanation for the different selectivities observed for the MAO isoforms. In vitro biological studies using LPS-stimulated rat astrocytes showed that some compounds were able to counteract the oxidative stress-induced neuroinflammation and hamper interleukin-6 secretion, confirming the success of this multitarget approach.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Antioxidants (Basel, Switzerland) - 12(2023), 12 vom: 25. Nov. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Berrino, Emanuela [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Carbonic anhydrase |
|---|
| Anmerkungen: |
Date Revised 25.12.2023 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3390/antiox12122044 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366268295 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366268295 | ||
| 003 | DE-627 | ||
| 005 | 20231227141046.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231227s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/antiox12122044 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1238.xml |
| 035 | |a (DE-627)NLM366268295 | ||
| 035 | |a (NLM)38136164 | ||
| 035 | |a (PII)2044 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Berrino, Emanuela |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A Multitarget Approach against Neuroinflammation |b Alkyl Substituted Coumarins as Inhibitors of Enzymes Involved in Neurodegeneration |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 25.12.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Neurodegenerative disorders (NDs) include a large range of diseases characterized by neural dysfunction with a multifactorial etiology. The most common NDs are Alzheimer's disease and Parkinson's disease, in which cholinergic and dopaminergic systems are impaired, respectively. Despite different brain regions being affected, oxidative stress and inflammation were found to be common triggers in the pathogenesis and progression of both diseases. By taking advantage of a multi-target approach, in this work we explored alkyl substituted coumarins as neuroprotective agents, capable to reduce oxidative stress and inflammation by inhibiting enzymes involved in neurodegeneration, among which are Carbonic Anhydrases (CAs), Monoamine Oxidases (MAOs), and Cholinesterases (ChEs). The compounds were synthesized and profiled against the three targeted enzymes. The binding mode of the most promising compounds (7 and 9) within MAO-A and -B was analyzed through molecular modeling studies, providing and explanation for the different selectivities observed for the MAO isoforms. In vitro biological studies using LPS-stimulated rat astrocytes showed that some compounds were able to counteract the oxidative stress-induced neuroinflammation and hamper interleukin-6 secretion, confirming the success of this multitarget approach | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Parkinson’s disease | |
| 650 | 4 | |a carbonic anhydrase | |
| 650 | 4 | |a cholinesterase | |
| 650 | 4 | |a coumarin | |
| 650 | 4 | |a inhibitors | |
| 650 | 4 | |a monoamine oxidase (MAO) | |
| 650 | 4 | |a neuroinflammation | |
| 700 | 1 | |a Carradori, Simone |e verfasserin |4 aut | |
| 700 | 1 | |a Carta, Fabrizio |e verfasserin |4 aut | |
| 700 | 1 | |a Melfi, Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Gallorini, Marialucia |e verfasserin |4 aut | |
| 700 | 1 | |a Poli, Giulio |e verfasserin |4 aut | |
| 700 | 1 | |a Tuccinardi, Tiziano |e verfasserin |4 aut | |
| 700 | 1 | |a Fernández-Bolaños, José G |e verfasserin |4 aut | |
| 700 | 1 | |a López, Óscar |e verfasserin |4 aut | |
| 700 | 1 | |a Petzer, Jacobus P |e verfasserin |4 aut | |
| 700 | 1 | |a Petzer, Anél |e verfasserin |4 aut | |
| 700 | 1 | |a Guglielmi, Paolo |e verfasserin |4 aut | |
| 700 | 1 | |a Secci, Daniela |e verfasserin |4 aut | |
| 700 | 1 | |a Supuran, Claudiu T |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Antioxidants (Basel, Switzerland) |d 2012 |g 12(2023), 12 vom: 25. Nov. |w (DE-627)NLM256601127 |x 2076-3921 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2023 |g number:12 |g day:25 |g month:11 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/antiox12122044 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2023 |e 12 |b 25 |c 11 | ||